D. E. Shaw & Co., Inc. Johnson & Johnson Call Options Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$145.48 - $167.38 $7.96 Million - $9.16 Million	-54,700 Reduced 10.55%	464,000 $75.2 Million
Q2 2024 Aug 14, 2024	SELL	$144.38 - $157.78 $29.1 Million - $31.8 Million	-201,500 Reduced 27.98%	518,700 $75.8 Million
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $117 Million - $123 Million	-754,800 Reduced 51.17%	720,200 $114 Million
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $31 Million - $33.8 Million	213,000 Added 16.88%	1,475,000 $231 Million
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $13.3 Million - $14.9 Million	85,300 Added 7.25%	1,262,000 $197 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $50.4 Million - $54.3 Million	326,600 Added 38.42%	1,176,700 $195 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $66.7 Million - $79.6 Million	441,600 Added 108.1%	850,100 $132 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $42.4 Million - $47.6 Million	-264,500 Reduced 39.3%	408,500 $72.2 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $39.5 Million - $44 Million	245,000 Added 57.24%	673,000 $110 Million
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $28.3 Million - $31.2 Million	168,000 Added 64.62%	428,000 $76 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $42.4 Million - $48.2 Million	-268,200 Reduced 50.78%	260,000 $46.1 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $48 Million - $53.3 Million	307,900 Added 139.76%	528,200 $90.4 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $39.5 Million - $43.8 Million	-244,300 Reduced 52.58%	220,300 $35.6 Million
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $68.6 Million - $73.5 Million	429,900 Added 1238.9%	464,600 $76.5 Million
Q1 2021 May 17, 2021	SELL	$153.07 - $170.48 $811,271 - $903,544	-5,300 Reduced 13.25%	34,700 $5.7 Million
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $20.3 Million - $23.3 Million	-147,900 Reduced 78.71%	40,000 $6.3 Million
Q3 2020 Nov 16, 2020	BUY	$140.38 - $153.83 $1.88 Million - $2.06 Million	13,400 Added 7.68%	187,900 $28 Million
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $17 Million - $20.5 Million	-132,100 Reduced 43.09%	174,500 $24.5 Million
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $14 Million - $19.5 Million	-126,400 Reduced 29.19%	306,600 $40.2 Million
Q4 2019 Feb 14, 2020	BUY	$127.5 - $146.44 $13.6 Million - $15.6 Million	106,800 Added 32.74%	433,000 $63.2 Million
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $20.5 Million - $23 Million	161,700 Added 98.3%	326,200 $42.2 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $33.2 Million - $36.5 Million	-253,200 Reduced 60.62%	164,500 $22.9 Million
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $31.9 Million - $35.5 Million	253,600 Added 154.54%	417,700 $58.4 Million
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $21.6 Million - $26 Million	-175,900 Reduced 51.74%	164,100 $21.2 Million
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $14.5 Million - $17 Million	-119,100 Reduced 25.94%	340,000 $47 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $5.77 Million - $6.36 Million	48,300 Added 11.76%	459,100 $55.7 Million
Q1 2018 May 15, 2018	SELL	$125.1 - $148.14 $18.2 Million - $21.6 Million	-145,800 Reduced 26.19%	410,800 $52.6 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $8.83 Million - $9.67 Million	67,300 Added 13.75%	556,600 $77.8 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $63.3 Million - $66.2 Million	489,300	489,300 $63.6 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account